Investment Summary |
|
|---|---|
| Date | 2009-10-30 |
| Target | PDC |
| Sector | Healthcare Services |
| Investor(s) | Andera Partners |
| Deal Type | Venture |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2001 |
| PE ASSETS | 3.7B EUR |
| Size | Large |
| Type | Sector Agnostic |
Andera Partners is a private investment firm focused on several strategies. The Firm invests in life science opportunities through its BioDiscovery group. The Firm invests in Western European small to mid-sized companies (€30 to €300 million of revenue) through its Winch Capital group. Andera invests in small to mid-sized French companies (€10 to €100 million of revenue) through its Cabestan Capital team. Andera invests in €5 to €45 million of mezzanine capital to support small to mid-sized French companies. Andera Partners was established in 2001 and is headquartered in Paris.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 106 |
| Sector: Healthcare Services M&A | 1 of 4 |
| Type: Venture M&A Deals | 1 of 28 |
| Country: Australia M&A | 1 of 1 |
| Year: 2009 M&A | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-12-17 |
MDxHealth
Herstal, Belgium MDxHealth is a molecular diagnostics company that develops and commercializes advanced tests for cancer assessment and the personalized treatment of patients. MDxHealth was founded in 2003 and is based in Herstal, Belgium. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-11-02 |
Vivoryon Therapeutics
Halle, Germany Vivoryon Therapeutics is a biopharmaceutical company focused on the development and commercialisation of new therapeutic products for the treatment of alzheimer’s disease (“AD”). Vivoryon Therapeutics was founded in 1997 and is based in Halle, Germany. |
Buy | - |
